Selva

Xeptiva

UruguayHealthtech

Xeptiva Therapeutics is a Uruguayan clinical-stage biotech startup developing advanced therapeutic vaccines for chronic conditions in pets, such as chronic pain and atopic dermatitis. The company's technology platform uses a proprietary vaccine approach to induce the animal's immune system to produce antibodies against disease-causing targets, offering a long-lasting alternative to daily medications. Xeptiva targets the veterinary market, focusing on companion animals, and operates primarily from Uruguay. It raised a $2.5 million seed round led by Zentynel, a Chilean biotech fund, and has an active clinical trial program.

Website

2 funding rounds tracked. Amounts, dates and investors are available to premium members.
Unlock full funding history

Key people